Allergic rhinitis: Incidence and remission from childhood to young adulthood—A prospective study
Pediatric Allergy and Immunology · 2025-04 · 36 (4)
DOI: 10.1111/pai.70078 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Allergy and Immunology, online erschienen am 02.04.2025. Verfasst von Styliana Vasileiadou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Rhinitis, Allergic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Swedish Heart-Lung Foundation, The Swedish Asthma-Allergy Foundation, The Swedish Research Council.
Abstract (Originalsprache)
Background
Longitudinal studies on allergic rhinitis (AR) incidence and remission from childhood to adulthood are limited. This study aimed to estimate AR incidence and remission from age 8 to 19 years and to identify related risk factors.
Methods
In 2006, all children in grades 1 and 2 (median age 8 years) in three municipalities in Northern Sweden were invited to participate in a questionnaire survey. The children in two of the municipalities underwent a skin prick test (SPT) for airborne allergens. The protocol was repeated at age 19 years. In total, 2250 participants (91% participation rate) completed the questionnaire, and 1338 underwent SPTs at 8 and 19 years of age.
Results
From age 8 to 19 years, the cumulative incidence of AR was 33.6%, significantly higher among girls than boys (37.4% vs. 29.8%, p < .001). Factors that independently increased the risk of developing AR were sensitisation by age 8 (adjusted odds ratio [aOR] 3.75, 95% confidence interval [CI] 2.68–5.23), sensitisation between 8 and 19 years (aOR 2.57, 95% CI 1.82–3.63), and female sex (aOR 1.71, 95% CI 1.30–2.26). The remission rate was 40.0%, with boys experiencing significantly higher remission than girls (45.4% vs. 32.2%, p = .015). The probability of remission was decreased by sensitisation before (aOR 0.26, 95% CI 0.13–0.53) and after age 8 years (aOR 0.20, 95% CI 0.05–0.77).
Conclusion
This study found a high incidence of AR between age 8 and 19 years, especially among girls, while boys had a higher remission rate. Sensitisation increased the risk of developing AR and decreased the remission rate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Paediatrics, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Department of Public Health and Clinical Medicine, The OLIN Unit, Umeå University, Umeå, Sweden.
ORCID-Profile: Styliana Vasileiadou, Emma Goksör, Göran Wennergren, Eva Rönmark, Linnea Hedman
Förderung
- The Swedish Heart-Lung Foundation
- The Swedish Asthma-Allergy Foundation
- The Swedish Research Council
- The Swedish Foundation for Health Care Science and Allergy Research (Vårdal)
- Visare Norr
- Norbotten County Council
- ALF - the regional agreement between the Umeå University and Västerbotten County Council
- The Umeå University
Zitieren
APA
Vasileiadou, S., Goksör, E., Wennergren, G., Rönmark, E., & Hedman, L. (2025). Allergic rhinitis: Incidence and remission from childhood to young adulthood—A prospective study. Pediatric Allergy and Immunology, 36(4). https://doi.org/10.1111/pai.70078
Vancouver
Vasileiadou S, Goksör E, Wennergren G, Rönmark E, Hedman L. Allergic rhinitis: Incidence and remission from childhood to young adulthood—A prospective study. Pediatric Allergy and Immunology. 2025;36(4). doi:10.1111/pai.70078
BibTeX
@article{Vasileiadou2025,
author = {Vasileiadou, Styliana and Goksör, Emma and Wennergren, Göran and Rönmark, Eva and Hedman, Linnea},
title = {Allergic rhinitis: Incidence and remission from childhood to young adulthood—A prospective study},
journal = {Pediatric Allergy and Immunology},
year = {2025},
volume = {36},
number = {4},
doi = {10.1111/pai.70078}
}
EUVIMED